RA
Royce & Associates Portfolio holdings
AUM
$9.74B
1-Year Return
15.99%
This Quarter Return
-0.65%
1 Year Return
+15.99%
3 Year Return
+81.23%
5 Year Return
+192.6%
10 Year Return
+438.14%
AUM
$10.7B
AUM Growth
-$506M
(-4.5%)
Cap. Flow
-$208M
Cap. Flow
% of AUM
-1.94%
Top 10 Holdings %
Top 10 Hldgs %
9.5%
Holding
932
New
60
Increased
296
Reduced
331
Closed
64
Top Buys
| 1 |
MRX
Marex Group
MRX
|
$26.4M |
| 2 |
Enovis
ENOV
|
$20.7M |
| 3 |
Academy Sports + Outdoors
ASO
|
$20M |
| 4 |
Banc of California
BANC
|
$19.8M |
| 5 |
Atkore
ATKR
|
$16.1M |
Top Sells
| 1 |
FormFactor
FORM
|
$35.4M |
| 2 |
FTAI Aviation
FTAI
|
$27.4M |
| 3 |
IBTX
Independent Bank Group, Inc.
IBTX
|
$27.1M |
| 4 |
Ares Management
ARES
|
$20M |
| 5 |
Lincoln Electric
LECO
|
$18.9M |
Sector Composition
| 1 | Industrials | 26.66% |
| 2 | Technology | 20.61% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 11.61% |
| 5 | Healthcare | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Agios Pharmaceuticals
AGIO
$2.09B
| – | – |
-7,338
| Closed | -$215K |
|
877
AirSculpt Technologies
AIRS
$368M
| – | – |
-17,187
| Closed | -$106K |
|
878
Allient
ALNT
$772M
| – | – |
-61,450
| Closed | -$2.19M |
|
879
Amplify Energy
AMPY
$155M
| – | – |
-15,778
| Closed | -$104K |
|
880
Andersons Inc
ANDE
$1.42B
| – | – |
-3,744
| Closed | -$215K |
|
881
Bio-Rad Laboratories Class A
BIO
$8B
| – | – |
-22,847
| Closed | -$7.9M |
|
882
Peabody Energy
BTU
$2.33B
| – | – |
-8,379
| Closed | -$203K |
|
883
BlueLinx
BXC
$680M
| – | – |
-12,312
| Closed | -$1.6M |
|
884
Calix
CALX
$3.96B
| – | – |
-45,594
| Closed | -$1.51M |
|
885
Avis
CAR
$5.5B
| – | – |
-1,661
| Closed | -$203K |
|
886
C4 Therapeutics
CCCC
$194M
| – | – |
-23,604
| Closed | -$193K |
|
887
ClearPoint Neuro
CLPT
$314M
| – | – |
-29,205
| Closed | -$199K |
|
888
Comtech Telecommunications
CMTL
$65.3M
| – | – |
-634,353
| Closed | -$2.18M |
|
889
Core & Main
CNM
$12.7B
| – | – |
-95,856
| Closed | -$5.49M |
|
890
Charles River Laboratories
CRL
$8.07B
| – | – |
-15,592
| Closed | -$4.22M |
|
891
CVRx
CVRX
$204M
| – | – |
-114,000
| Closed | -$2.08M |
|
892
Denny's
DENN
$237M
| – | – |
-1,911,618
| Closed | -$17.1M |
|
893
1stdibs.com
DIBS
$100M
| – | – |
-274,439
| Closed | -$1.64M |
|
894
Krispy Kreme
DNUT
$579M
| – | – |
-166,035
| Closed | -$2.53M |
|
895
Establishment Labs
ESTA
$1.13B
| – | – |
-15,625
| Closed | -$795K |
|
896
Fate Therapeutics
FATE
$116M
| – | – |
-43,399
| Closed | -$319K |
|
897
Kymera Therapeutics
KYMR
$3.11B
| – | – |
-7,076
| Closed | -$284K |
|
898
Laureate Education
LAUR
$4.1B
| – | – |
-50,000
| Closed | -$729K |
|
899
Lifecore Biomedical
LFCR
$282M
| – | – |
-75,610
| Closed | -$401K |
|
900
Liquidia Corp
LQDA
$2.48B
| – | – |
-24,000
| Closed | -$354K |
|